Search

Purpose: To assess the long-term stability of gingival grafts placed around dental implants at the time of second surgery uncovering and to further investigate the association between mucosal thickness (MTh) by demographic variables and clinical investigation. Materials and Methods: Fourteen patients with submerged dental implants covered by inadequate keratinized mucosa were studied. The subjects underwent a periimplant plastic surgery (PPS) at the second-stage dental implant surgery and free gingival autograft orsubepithelial connective tissue graft were used according to the patients′ clinical situation. Clinical measurement of MTh was assessed by bone sounding with a periodontal probe using customized acrylic stents andthe values were recorded at baseline (day of graft) and at 0.5, 1.5, 4, 12, 24 and 36 months after grafting. Results: At 12 months postoperatively, the mean MTh was 2.89 mm, with a mean additional increase of 1.75 mm when compared with baseline (P=0.0001). No statistically significant differences in MTh were found between the 12- and the 36-month observations (P=0.09). In addition, at 36 months, a thin mucosa was associated with a greater increase in the MTh compared with a thick mucosa (2.14 and 0.64 mm, respectively, P=0.006). Similarly, the mandibular sites were associated with a greater increase in the MTh in comparison with the maxillary sites (2.17 and 0.81 mm, respectively; P=0.02). Conclusions: Within the limitations of this investigation, the data suggest that PPS at the second-stage dental implant surgery could results in additional increases in MTh, especially when it is performed in areas where the mucosa is of a thin biotype.

The aim of this study was to retrospectively evaluate 75 implants inserted in vertically augmented bone at the time of or prior to implant placement after 1 to 6 years of prosthetic loading. The study included 21 patients (29 surgical sites). The vertical procedure was performed combining a titanium-reinforced expanded polytetrafluoroethylene membrane with autograft (7 sites), allograft (5 sites), or auto-xenograft (17 sites). Healing was uneventful in 24 surgical sites. Three sites showed premature exposure, and two sites presented an abscess. Two implants were lost, for a cumulative survival rate of 93.6%. Mean bone remodeling at 1, 2, 3, 4, 5, and 6 years was 0.34, 0.72, 1.04, 0.84, 0.56, and 0.61 mm, respectively. The implant success rate was higher with a simultaneous approach (82.5%) compared with a staged approach (66.8%). Implants surrounded by keratinized mucosa revealed a higher success rate (82.1%) than those without it (58.4%). [ABSTRACT FROM AUTHOR]

Background: Transferring results obtained in cardiovascular outcome trials (CVOTs) to the real-world setting is challenging. We herein transposed CVOT results to the population of patients with type 2 diabetes (T2D) seen in routine clinical practice and who may receive the medications tested in CVOTs. Methods: We implemented the post-stratification approach based on aggregate data of CVOTs and individual data of a target population of diabetic outpatients. We used stratum-specific estimates available from CVOTs to calculate expected effect size for the target population by weighting the average of the stratum-specific treatment effects according to proportions of a given characteristic in the target population. Data are presented as hazard ratio (HR) and 95% confidence intervals. Results: Compared to the target population (n = 139,708), the CVOT population (n = 95,816) was younger and had a two to threefold greater prevalence of cardiovascular disease. EMPA-REG was the CVOT with the largest variety of details on stratum-specific effects, followed by TECOS, whereas DECLARE and PIONEER-6 had more limited stratum-specific information. The post-stratification HR estimate for 3 point major adverse cardiovascular event (MACE) based on EMPA-REG was 0.88 (0.74–1.03) in the target population, compared to 0.86 (0.74–0.99) in the trial. The HR estimate based on LEADER was 0.88 (0.77–0.99) in the target population compared to 0.87 (0.78–0.97) in the trial. Consistent results were obtained for SUSTAIN-6, EXSCEL, PIONEER-6 and DECLARE. The effect of DPP-4 inhibitors observed in CVOTs remained neutral in the target population. Conclusions: Based on CVOT stratum-specific effects, cardiovascular protective actions of glucose lowering medications tested in CVOTs are transferrable to a much different real-world population of patients with T2D. [ABSTRACT FROM AUTHOR]

Objective: The surgical extraction of an impacted third molar involves a wide range of consequences such as trismus, swelling, and pain, as well as more significant complications, temporary or permanent, that can manifest altered sensitivity of the tongue or lips. The purpose of this prospective study was to evaluate the effects of three different flaps on postoperative discomfort considering trismus, edema, and pain, after the extraction of impacted third molars. The data derived from the analysis of the surgical trials performed at the Oral Surgery Unit, Department of Surgical, Reconstructive and Diagnostic Sciences, IRCCS Policlinico, University of Milan, directed by Professor F. Santoro, MD. Method and Materials: This study, developed over 2 years, involved 238 patients for a total of 238 extractions of impacted mandibular third molars. The 238 surgeries were performed on 114 men and 124 women: 54 avulsions were performed with the elevation of an envelope flap (Group 1), 48 avulsions through the elevation of a triangular flap (Group 2), and the remaining 136 avulsions were performed using a trapezoidal flap (Group 3). Results: Trismus was significantly reduced (P < .05) in patients treated with envelope flap, as was the swelling perceived by the patient (P < .05). Pain was closely related to the elevation of a mucoperiosteal flap and osteotomy. Our study does not reveal statistically significant differences between the three types of flap used; however, the number of analgesic tablets taken was lower in cases of elevation of a less traumatic flap (envelope and triangular flaps). Conclusion: The data collected in this study indicate the envelope flap as the most suitable for the reduction of the expression of postoperative complications such as swelling and trismus. [ABSTRACT FROM AUTHOR]

Aims: According to cardiovascular outcome trials, some sodium‐glucose contransporter‐2 inhibitors (SGLT2i) and glucagon‐like peptide‐1 receptor agonists (GLP‐1RA) are recommended for secondary cardiovascular prevention in type 2 diabetes (T2D). In this real‐world study, we compared the simultaneous reductions in HbA1c, body weight and systolic blood pressure after initiation of dapagliflozin or GLP‐1RA as second or a more advanced line of therapy. Materials and methods: DARWIN‐T2D was a retrospective multi‐centre study conducted at diabetes specialist clinics in Italy that compared T2D patients who initiated dapagliflozin or GLP‐1RA (exenatide once weekly or liraglutide). Data were collected at baseline and at the first follow‐up visit after 3 to 12 months. The primary endpoint was the proportion of patients achieving a simultaneous reduction in HbA1c, body weight and systolic blood pressure. To reduce confounding, we used multivariable adjustment (MVA) or propensity score matching (PSM). Results: Totals of 473 patients initiating dapagliflozin and 336 patients initiating GLP‐1RA were included. The two groups differed in age, diabetes duration, HbA1c, weight and concomitant medications. The median follow‐up was 6 months in both groups. Using MVA or PSM, the primary endpoint was observed in 30% to 32% of patients, with no difference between groups. Simultaneous reduction of HbA1c, BP and SBP by specific threshold, as well as achievement of final goals, did not differ between groups. GLP‐1RA reduced HbA1c by 0.3% more than the reduction achieved with dapagliflozin. Conclusion: In routine specialist care, initiation of dapagliflozin can be as effective as initiation of a GLP‐1RA for attainment of combined risk factor goals. [ABSTRACT FROM AUTHOR]

Objectives: To show a clinical case in which impacted upper third molars caused resorption of the adjacent second molars root. Case report: A 26 year-old woman presented bilateral resorption of upper second molars caused by impacted third molars. Conclusions: Resorption of the second molars in the case presented could be avoided by preventive extraction of the upper third molars. Clinical significance: Resorption of upper second molars must be considered examining carefully in early stages the position of the third molars in the radiographies. [ABSTRACT FROM AUTHOR]

Purpose: Aim of the present study was to present the results of a retrospective analysis of maxillary sinus augmentation procedures performed with platelet-rich plasma (PRP) with a mean follow-up of about 5 years. The analysis was focused on implant survival rates and on the dimensional stability of the subantral cavity filling. Materials and Methods: Between 2000 and 2006, 28 patients were recruited for a maxillary sinus augmentation procedure performed with PRP. Two patients did not answer to the calling for the examination at distance, so they were excluded from the sample. The study involved 26 patients, for a total amount of 33 sinus augmentations, with an average follow-up of 65 months. In 26 procedures the grafting material used was a mixture of autologous bone taken from the oral cavity, deproteinized bovine bone Bio-Oss® in a relationship of 1:3 and PRP, while in seven cases, the combination of Bio-Oss and PRP. The dimensional stability of grafting material was investigated through X-ray measurements carried out during X-ray postexaminations. Results: After a mean follow-up time of about 5 years, the implant survival rate registered was 95.9%, while the radiographical variables used to assess the dimensional stability of grafts, showed a mean decrease respectively of 9.38% and 14.61%. Discussion: Very good long-term results were achieved using autologous bone+Bio-Oss+PRP and Bio-Oss+PRP as filling materials in the maxillary sinus augmentation. Dimensional stability of cavity filling seems to represent a very important factor for implant procedures success. It is difficult to estimate the influence of PRP on a long-term basis. Conclusion: The implant survival rate obtained in this study was similar to the expected rate on the areas not subject to bone graft. The method applied showed to be reliable for bone regeneration in subantral cavities, showing a very good dimensional stability and a slight reabsorption over the years. [ABSTRACT FROM AUTHOR]

Propose: The aim of this work is to present a case report of an accidentally displaced upper third molar in the infratemporal fossa. The surgery and the clinical evaluation of this rare situation are discussed and compared with the recent international literature. Methods: A young patient affected by upper third molar located in the infratemporal fossa was evaluated in this case report. Before surgery, radiographic examinations were done with the use of orthopantomograph, and computed axial tomography. Results: Antimicrobial prophylaxis was obtained with 1000 mg amoxicillin twice daily for 5 days starting 1 day before surgery. Topical anesthetic was used; mucoperiostal flap was elevated by electrosurgical device (Bladion ®) and after cortical bone was exposed. Then soft tissues dissection was performed by blunt scissor (Metzenbaum): tooth was founded and then extracted. Clinical Significance: The accidental displacement of the upper third molar in the infratemporal fossa caused by attempted extraction is a potentially condition in oral surgery. This case report wants the clinicians to evaluate the surgical technique and the management of this rare condition. Retrieval should be performed as soon as possible when this condition appears to avoid clinical complications and tissue reactions. OPT and TC images are important to point out the exact position of the impacted tooth and to accomplish the surgery. [ABSTRACT FROM AUTHOR]

Objectives: The aim of this study was to compare the efficacy of the transobturator tape (TOT) procedure combined with solifenacin (TOT-S) or prasterone (TOT-P) in postmenopausal women affected by mixed urinary incontinence (MUI) with a predominant stress urinary incontinence component., Methods: This is a retrospective analysis including 112 patients: 60 patients of the TOT-S group and 52 patients of the TOT-P group. Physical examination, 3-day voiding diary, urodynamic tests, and Vaginal Health Index (VHI) were compared at the beginning of the analysis and after 12 weeks of follow-up (FU). Specific questionnaires were administered to indagate the impact on women's quality of life and sexual function., Results: After 12 weeks of FU, the detrusor's peak flow pressure was significantly different between the two groups (p = .02). Detrusor overactivity decreased only in the TOT-P group (p = .05). At the end of FU, 58 patients (96.7%) of the TOT-S group and 50 patients (96.2%) of the TOT-P group were dry at the stress test. A significative group difference was observed in urge urinary incontinence (24 h) (p = .01) but not in the mean number of voids (24 h) and urgent micturition events (24 h). VHI improved only in the TOT-P group (12.57 ± 3.80 vs. 19.75 ± 4.13, p < .0001). The questionnaires and Patient Global Index of Improvement (PGI-I) scores showed comparable improvements, while the Female Sexual Function Index improved especially in the TOT-P group (p < .001)., Conclusions: In postmenopausal women with MUI, TOT-P demonstrated the same effectiveness as TOT-S in reducing urinary symptoms. In addition, TOT-P increased VHI and sexual function scores compared with TOT-S., (© 2023 John Wiley & Sons Australia, Ltd.)

Background: This study investigates retrospectively if the initial electromyography (EMG) status of patients who underwent orthognathic surgery correlates with the extent of postsurgical EMG functional recovery., Methods: Clinical records concerning 20 patients who underwent Le Fort I and/or sagittal osteotomy of the mandibular ramus to correct skeletal dental class III malocclusions were retrieved and presurgical and postsurgical EMG data were analyzed and compared. Additionally, postsurgical EMG recovery was compared with that of a set of healthy, not surgically treated class I patients, with no sign of disorders affecting the temporomandibular joint (TMJ). Finally, the effect of six independent variables (age, sex, time from surgery, extent of segment re-positioning, malocclusion class, upper jaw repositioning) on muscular recovery was investigated by means of correlation analysis., Results: A significant increase of the average EMG activity after orthognathic corrective surgery was observed (P=0.01). The postsurgical increase of EMG values showed a negative correlation trend with those collected before surgery (r=-0.38, clenching on teeth; r=-0.33, clenching on cotton rolls). None of the independent variables had any effect on the postsurgical outcome., Conclusions: Orthognathic surgery improves the muscular activity of patients who present skeletal dental class III malocclusions. This improvement can be objectively assessed with EMG measurements. Patients who benefit more from orthognathic surgery seem to be those displaying the lowest presurgical EMG activity.